- Home
- MIST vs LOAN Comparison
MIST vs LOAN Comparison
Compare MIST & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MIST
- LOAN
- Stock Information
- Founded
- MIST 2003
- LOAN 1989
- Country
- MIST Canada
- LOAN United States
- Employees
- MIST N/A
- LOAN N/A
- Industry
- MIST Biotechnology: Pharmaceutical Preparations
- LOAN Real Estate Investment Trusts
- Sector
- MIST Health Care
- LOAN Real Estate
- Exchange
- MIST Nasdaq
- LOAN Nasdaq
- Market Cap
- MIST 89.8M
- LOAN 58.1M
- IPO Year
- MIST N/A
- LOAN 1999
- Fundamental
- Price
- MIST $1.92
- LOAN $5.47
- Analyst Decision
- MIST Strong Buy
- LOAN
- Analyst Count
- MIST 2
- LOAN 0
- Target Price
- MIST $7.50
- LOAN N/A
- AVG Volume (30 Days)
- MIST 613.1K
- LOAN 12.8K
- Earning Date
- MIST 08-07-2025
- LOAN 07-21-2025
- Dividend Yield
- MIST N/A
- LOAN 8.41%
- EPS Growth
- MIST N/A
- LOAN N/A
- EPS
- MIST N/A
- LOAN 0.48
- Revenue
- MIST N/A
- LOAN $7,291,468.00
- Revenue This Year
- MIST N/A
- LOAN N/A
- Revenue Next Year
- MIST N/A
- LOAN $4.41
- P/E Ratio
- MIST N/A
- LOAN $11.40
- Revenue Growth
- MIST N/A
- LOAN N/A
- 52 Week Low
- MIST $0.63
- LOAN $4.74
- 52 Week High
- MIST $2.75
- LOAN $6.05
- Technical
- Relative Strength Index (RSI)
- MIST 67.01
- LOAN 60.29
- Support Level
- MIST $1.85
- LOAN $5.12
- Resistance Level
- MIST $2.02
- LOAN $5.20
- Average True Range (ATR)
- MIST 0.09
- LOAN 0.10
- MACD
- MIST 0.01
- LOAN 0.02
- Stochastic Oscillator
- MIST 73.75
- LOAN 100.00
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.